Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Fred Hutchinson Cancer Center
Stanford University
IGF Oncology, LLC
Medical College of Wisconsin
National Cancer Institute (NCI)
City of Hope Medical Center
Virginia Commonwealth University
M.D. Anderson Cancer Center
Albert Einstein College of Medicine
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Brown University
Roswell Park Cancer Institute
University of Washington
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Neovii Biotech
Case Comprehensive Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
University of Washington
Indiana University
University of California, Davis
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
University of Washington
OHSU Knight Cancer Institute
National Cancer Institute (NCI)